LIVE

Serial Number

79168870

Owner

AM-Pharma B.V.

Attorney

James C. Watson

Filing Date

Mar 3, 2015

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

STOP-AKI Trademark

Serial Number: 79168870 • Registration: 4911567

STOP-AKI is a trademark filed by AM-Pharma B.V. on March 3, 2015. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Trademark Classes

Class 1 - Chemicals

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

AM-Pharma B.V. (5 trademarks)

Stadsplateau 6
NL-3521 AZ Utrecht , NL

Entity Type: 16

Legal Representation

Attorney of Record

James C. Watson

723 trademarks filed View all →

Correspondence Address

James C. Watson TraskBritt, P.C.

230 South 500 East, #300

Salt Lake City, UT 84102

UNITED STATES

Trademark Details

Filing Date

March 3, 2015

Registration Date

March 8, 2016

Published for Opposition

December 22, 2015

Cancellation Date

March 3, 2025

Goods & Services

[ Pharmaceutical preparations in the field of inflammatory diseases and kidney diseases; diagnostic preparations in the field of inflammatory diseases and kidney diseases for medical use; enzyme preparations in the field of inflammatory diseases and kidney diseases for medical use; medicines for human purposes for the treatment of inflammatory diseases and kidney diseases ]

[ Protein arrays for use in recombinant DNA scientific and medical research other than for medical diagnostic use; recombinant nucleic acid for laboratory use; diagnostic preparations and reagents for scientific or research purposes in the field of inflammatory diseases and kidney diseases, other than for medical use; diagnostic sets consisting of diagnostic preparations with test receptors and reagents for testing of selected bacteria for scientific or research use; chemicals for use in the production of medicines for the treatment of inflammatory diseases and kidney diseases ]

Scientific research, technological research and industrial research; development of technologies, diagnostics, medicines and dietary supplements; biotechnology research in the field of enzymatic synthesis; product testing, authentication and quality control for others; performing clinical trials for others; medical and pharmaceutical research services; provision of medical and scientific research information in the field of pharmaceuticals and clinical trials; research related to medicines, all the aforementioned related to the treatment of inflammatory diseases and kidney diseases

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED

Sep 26, 2025 DENA

DEATH OF INTERNATIONAL REGISTRATION

Sep 26, 2025 DETH

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

Mar 8, 2025 REM4

PARTIAL INVALIDATION PROCESSED BY THE IB

Jul 3, 2023 INNP

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

May 19, 2023 INPS

INVALIDATION PROCESSED

May 19, 2023 INPC

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

Apr 5, 2023 INPR

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

Aug 5, 2022 NA71

REGISTERED - PARTIAL SEC 71 ACCEPTED

Aug 5, 2022 71.P

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Aug 2, 2022 APRE

TEAS SECTION 71 RECEIVED

Mar 8, 2022 ES71

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

Mar 8, 2021 REM3

CHANGE OF NAME/ADDRESS REC'D FROM IB

May 14, 2020 ADCH

FINAL DECISION TRANSACTION PROCESSED BY IB

Jul 9, 2016 FINO

FINAL DISPOSITION NOTICE SENT TO IB

Jun 21, 2016 FICS

FINAL DISPOSITION PROCESSED

Jun 21, 2016 FIMP

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Jun 8, 2016 FICR

REGISTERED-PRINCIPAL REGISTER

Mar 8, 2016 R.PR

NOTIFICATION PROCESSED BY IB

Jan 4, 2016 GPNX

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 22, 2015 NPUB

PUBLISHED FOR OPPOSITION

Dec 22, 2015 PUBO

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Dec 16, 2015 OPNS

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Dec 16, 2015 OP2R

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 2, 2015 NONP

NEW REPRESENTATIVE AT IB RECEIVED

Oct 23, 2015 NREP

APPROVED FOR PUB - PRINCIPAL REGISTER

Oct 16, 2015 CNSA

EXAMINER'S AMENDMENT ENTERED

Oct 16, 2015 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Oct 16, 2015 GNEN

EXAMINERS AMENDMENT E-MAILED

Oct 16, 2015 GNEA

EXAMINERS AMENDMENT -WRITTEN

Oct 16, 2015 CNEA

TEAS/EMAIL CORRESPONDENCE ENTERED

Oct 15, 2015 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 14, 2015 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Oct 14, 2015 TROA

REFUSAL PROCESSED BY IB

Aug 15, 2015 RFNT

APPLICATION FILING RECEIPT MAILED

Jul 31, 2015 MAFR

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Jul 28, 2015 RFCS

REFUSAL PROCESSED BY MPU

Jul 28, 2015 RFRR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Jul 28, 2015 RFCR

NON-FINAL ACTION WRITTEN

Jul 27, 2015 CNRT

ASSIGNED TO EXAMINER

Jul 27, 2015 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 27, 2015 NWOS

LIMITATION FROM ORIGINAL APPLICATION ENTERED

Jul 22, 2015 LIMI

SN ASSIGNED FOR SECT 66A APPL FROM IB

Jul 16, 2015 REPR

Related Trademarks

More from this Owner

AM-PHARMA

AM PHARMA

REVIVAL

AM-PHARMA

More in Same Class

Serial #79167905